In-House CCIT Equipment vs Outsourced Testing Service: Which Should You Choose?

Zholion · Decision Guide · Updated 2026

1. Side-by-side comparison

2. When in-house equipment wins

• High or recurring volume. Once you test regularly, the per-test cost of owned equipment falls below repeated service fees.

• Release and process control. If CCIT results gate your batch release or feed process control, you cannot wait for a lab — you need results now.

• Confidentiality and control. Keeping sensitive product and defect data inside your own walls is sometimes mandatory.

• Long-term strategy. If the product line will exist for years, owning the capability pays back and gives you independence.

If you buy, choose equipment that is validation-ready and comes with method development and IQ/OQ/PQ support — see our guide on choosing a CCIT leak detector.

3. When outsourcing wins

• Low or intermittent volume. A few studies a year do not justify capital, a dedicated operator, and annual calibration.

• No in-house CCIT expertise yet. Method development and validation are specialised; an accredited lab brings the expertise immediately.

• Specialist or rare methods. If you occasionally need helium, laser headspace, or high-voltage testing, paying per study beats owning idle equipment.

• Accelerating IND/NDA. A lab that already knows FDA/EMA/CDE expectations can compress your submission timeline.

Zholion's third-party CCIT testing lab is CMA, CNAS, and cGMP accredited, has passed EU QP audits, and covers the full drug life cycle — from packaging development and USP <382> fit checks to process validation, stability studies, and release testing.

4. The hybrid path most companies actually take

In practice, the choice is rarely binary. The most common, lowest-risk sequence we see:

1. Outsource method development and validation to an accredited lab, so your method is right before you invest.

2. Outsource early-stage and specialist studies while volumes are low.

3. Bring routine testing in-house once volumes, methods, and processes are stable.

4. Keep the lab as back-up for capacity peaks, new products, and re-validation.

Choosing a partner that offers both equipment and services — like Zholion — means the method transfers cleanly from the lab to your own instrument, without the friction of switching vendors mid-journey.

5. Who we are — and the capacity behind both paths

Zholion, founded in 2005 in Shanghai, is both a detector manufacturer and a testing-service provider — one of the few partners that can support you on both sides of this decision.

• Equipment: detectors covering 100% of CCIT methods, from vacuum decay to helium, high-voltage, and laser headspace.

• Services: a CMA/CNAS/cGMP-accredited, EU-QP-audited lab covering the full product life cycle.

• Positive controls: in-house positive controls (laser-drilled, capillary, micropipette) for method validation and routine verification.

• Standards leadership: contributor to YY/T 0681.18 and the Chinese Pharmacopoeia 2025 CCIT standards.

6. Cases and markets

• 3,000+ service projects executed for pharmaceutical manufacturers, CRO/CMO/CDMO, testing institutions, and third-party labs.

• 2,000+ global clients across China and international markets.

• First Chinese vacuum decay testing service in 2018 — a marker of early and deep method expertise.

• Leading market share in CCIT positive controls in China, supplying calibrated defects from 0.1 µm to 100 µm.

7. Purchasing and after-sales

• Scope the whole life cycle. Whether you buy or outsource, plan for method development, validation, routine testing, and re-validation.

• Confirm accreditation. For services, confirm CMA/CNAS/cGMP and audit history; for equipment, confirm validation support and traceable controls.

• Plan the transfer. If you will move from service to in-house, confirm the method transfers cleanly to your instrument.

• After-sales. A named contact and response process protect you on either path — contact Zholion via our contact page or +86 400-888-0570.

If you go in-house: installation and maintenance experience

Owning a detector shifts the maintenance burden to you. These habits keep it validated and reliable:

• Controlled environment. Install on a stable, clean bench free of vibration and temperature swings, per the instrument's requirements.

• Scheduled calibration against traceable standards, on a documented calendar.

• Routine positive/negative control runs to confirm the detector still resolves the target leak size between calibrations.

• Fixture and seal care — O-rings, chamber surfaces, and connections wear and must be inspected and replaced on schedule.

• Operator training and documentation. Trained operators plus complete calibration and verification records are what keep an audit clean.

8. Frequently asked questions

How do I know if I should buy or outsource?

Look at your testing volume, frequency, and urgency. Frequent, release-critical testing justifies in-house equipment; intermittent or specialist testing favours outsourcing. Many companies do both.

Is outsourcing CCIT compliant with regulators?

Yes, provided the lab is properly accredited and audited. Zholion's lab holds CMA, CNAS, and cGMP accreditations and has passed EU QP audits, and our reports support FDA, EMA, and CDE submissions.

Can I outsource now and buy equipment later?

Yes — that is the most common path. Start with services for method development and validation, then bring routine testing in-house when volumes justify it.

Does the method transfer from your lab to my instrument?

Yes. Because Zholion provides both the lab and the equipment, the method transfers cleanly — the lab develops and validates it, and the same team supports your in-house instrument through the transfer.

What does outsourced CCIT cost?

It depends on the method, number of samples, and study scope. Contact us with your product and testing needs for a quote — via our contact page or +86 400-888-0570.

Do you support both equipment and services for the same project?

Yes. As both a manufacturer and a testing-service provider, Zholion can handle the entire journey — method development, validation, routine testing, and eventual in-house equipment — under one roof.

What if I outsource but later bring testing in-house?

That is the most common path, and it is exactly why choosing a partner that does both matters. Zholion develops and validates your method in the lab, then transfers it to your in-house instrument with the same team supporting the transfer — so nothing is lost between vendors.

Is outsourced data accepted in regulatory submissions?

Yes, when the lab is properly accredited and audited. Zholion's lab is CMA, CNAS, and cGMP accredited and has passed EU QP audits, and our reports support FDA, EMA, and CDE submissions.